← Back to headlines
FDA Selects Eli Lilly, Regeneron for Drug Manufacturing Pilot Program
Eli Lilly and Regeneron have been selected by the FDA to participate in a new pilot program designed to boost U.S. drug manufacturing. This initiative aims to speed up the review process for new manufacturing facilities.
29 Jun, 18:53 — 29 Jun, 21:50
The Story
Analyzing sources…
Source Diversity
Source Diversity
Moderate (27/100)2 sources— more sources would strengthen this score15/33
Spectrum spread— 2/5 buckets covered8/33
Far L
Left1
Left (1)
cnbc
Center
Right1
Right (1)
seeking-alpha
Far R
Geographic diversity— 1 region4/34
US2
ℹAll sources from US region
ℹOnly 2 sources cover this story
Sources
Showing 2 of 2 sources
cnbcMostly Factual40d ago
Eli Lilly, Regeneron among first companies selected for FDA initiative to speed review of new manufacturing facilities
Eli Lilly and Regeneron are among the first seven companies the FDA has selected for its PreCheck Pilot Program, CNBC has learned.
Read full article →seeking-alphaMixed40d ago
Eli Lilly, Regeneron named to FDA pilot program to boost US drug manufacturing
Read full article →Coverage Timeline
First report: cnbc · 29 Jun, 18:53|Full coverage: 2 · 3h|Window: 3h
Left-leaningCenterRight-leaning
